Quarterly Compliance Certificate for Q2 FY26 Submitted

Compliance View source PDF Explain this filing

NATCAPSUQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹157.50

prior close

₹162.93

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+1.3% vs market

Pharmaceuticals peers, median of 168sector-0.2%+1.8% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 1.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

-1.2

30m

-1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6+0.3+1.3-0.2+1.8

Next day

+0.9+1.1-0.3-0.3+1.2

-0.5+1.3-1.8-0.4-0.1

-1.5+2.0-3.5-0.7-0.8

-0.3+0.3-0.7-1.2+0.9

+1.6+1.1+0.5-1.0+2.5

-2.3-3.2+0.9-4.2+1.8

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Natural Capsules Limited submitted a certificate from its registrar Cameo Corporate Services under Regulation 74(5) of SEBI Depositories Regulations for the quarter ended September 30, 2026. The RTA confirms securities received from depository participants for dematerialisation were processed, the underlying securities remain listed, and physical certificates were cancelled with depository names updated as registered owners within stipulated timelines. Filed with both BSE and NSE.

Likely market impact

Routine quarterly regulatory filing with no material impact on shareholders or stock price.